Advancing
science
Pfizer’s relentless pursuit of cancer breakthroughs.
Cancer updates & breakthroughs
Treatment resistance: One of oncology’s challenges
Learn how researchers are working to address this challenge in cancer treatment.
How biomarkers can help find suitable treatments
Biomarkers can help care teams identify treatment options shown to be effective in lung cancer subtypes.
How antibody-drug conjugates (ADCs) might change treatment
Antibody-drug conjugates are changing the landscape of cancer treatments.
Predicting treatment responses and working to improve outcomes
Biomarkers may help predict outcomes and can provide understanding of the ways cancer responds to treatment.
The people behind the breakthroughs
Meet the minds turning the tide in cancer research.
Video_id: 6353387581112
Dr. Steffan Ho
Head, Translational Oncology at Pfizer
Steffan lost his father to cancer and now helps oncologists find the most effective, specific treatment for people they are treating.
Video_id: 6353386466112
Dr. Astrid Ruefli-Brasse
Head of Cancer Cell Biology, Pfizer Oncology
Astrid's personal journey to helping lead new cancer therapies began when she saw the impact neuroblastoma had on her younger cousin.
Video_id: 6353388237112
Dr. Scott Peterson
Head of ADC Discovery and Cancer Immunology, Pfizer Oncology
Scott's life's mission to take on cancer began at an early age with a passion for biology.
Video_id: 6353386670112
Dr. Kathleen Keegan
Head of Post-CAN Research, Pfizer Oncology
Kathleen's childhood dreams of being a doctor evolved when she fell in love with research.